Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Peter Voorhees"'
Autor:
Hamza Hashmi, Doris K. Hansen, Lauren C. Peres, Omar Castaneda Puglianini, Ciara Freeman, Gabriel De Avila, Surbhi Sidana, Leyla Shune, Douglas W. Sborov, James Davis, Charlotte Wagner, Mehmet H. Kocoglu, Shebli Atrash, Peter Voorhees, Gary Simmons, Christopher Ferreri, Nilesh Kalariya, Larry D. Anderson Jr., Aimaz Afrough, Danai Dima, Jack Khouri, Joseph McGuirk, Fred Locke, Rachid Baz, Krina K. Patel, Melissa Alsina
Publikováno v:
Haematologica, Vol 109, Iss 5 (2023)
While response rates and survival outcomes have been very promising for idecabtagene vicleucel (ide-cel), a proportion of patients do not respond or relapse early after this B-cell maturation antigen (BCMA) targeted chimeric antigen receptor (CAR) T-
Externí odkaz:
https://doaj.org/article/75a53724d8354ceda7fc08c876125b9e
Autor:
Surbhi Sidana, Lauren C. Peres, Hamza Hashmi, Hitomi Hosoya, Christopher Ferreri, Jack Khouri, Danai Dima, Shebli Atrash, Peter Voorhees, Gary Simmons, Douglas W. Sborov, Nilesh Kalariya, Vanna Hovanky, Sushma Bharadwaj, David Miklos, Charlotte Wagner, Mehmet H. Kocoglu, Gurbakhash Kaur, James A. Davis, Shonali Midha, Murali Janakiram, Ciara Freeman, Melissa Alsina, Frederick Locke, Rebecca Gonzalez, Yi Lin, Joseph McGuirk, Aimaz Afrough, Leyla Shune, Krina K. Patel, Doris K. Hansen
Publikováno v:
Haematologica, Vol 109, Iss 3 (2023)
We evaluated patients with relapsed multiple myeloma with renal impairment (RI) treated with standard of care idecabtagene vicleucel (ide-cel), as outcomes with chimeric antigen receptor (CAR) T-cell therapy are unknown in this population. RI was def
Externí odkaz:
https://doaj.org/article/e20fe1cc56fe454eae49245689ffabf6
Autor:
Paul G. Richardson, Brian G. Durie, Laura Rosiñol, Maria-Victoria Mateos, Angela Dispenzieri, Philippe Moreau, Shaji Kumar, Noopur Raje, Nikhil Munshi, Jacob P. Laubach, Peter O’Gorman, Elizabeth O’Donnell, Peter Voorhees, Thierry Facon, Joan Bladé, Sagar Lonial, Aurore Perrot, Kenneth C. Anderson
Publikováno v:
Haematologica, Vol 108, Iss 11 (2023)
To improve the outcomes of patients with the otherwise incurable hematologic malignancy of multiple myeloma (MM), a key paradigm includes initial treatment to establish disease control rapidly followed by maintenance therapy to ensure durability of r
Externí odkaz:
https://doaj.org/article/ff2c261954ee4ceb9b055acf9843022f
Autor:
Katja Weisel, Vania Hungria, Hang Quach, Sung-Soo Yoon, Paula Rodríguez-Otero, Glenn Kroog, Arijit Sinha, Anita Boyapati, Charlotte Lyon, Karen Rodriguez Lorenc, Timothy Inocencio, James Harnett, Lei Chi, Vygngley Moore, Peter Voorhees
Publikováno v:
HemaSphere, Vol 7, p e465366a (2023)
Externí odkaz:
https://doaj.org/article/331bd93f48144d34a96f1aff164681fb
Autor:
Cesar Rodriguez Valdes, Katja Weisel, Rachid Baz, Akshanth Polepally, Jeremy A. Ross, Ziyi Jin, Kristin D’amico, Orlando F. Bueno, Leanne Lash Fleming, Peter Voorhees
Publikováno v:
HemaSphere, Vol 7, p e60985f9 (2023)
Externí odkaz:
https://doaj.org/article/3928bd6ae4434486bf6eaef2cf4593fb
Autor:
Katja Weisel, Anita D’souza, David Hurd, Peter Voorhees, Raphael Teipel, Alfred Chung, Cesar Rodriguez, Sacha Tuchman, Neha Korde, Hana Safah, Orlando Bueno, Zhongling Feng, Tanya Rosenberg, Rajvineeth Kumar Pothacamury, Jeremy Ross, Shane Lee, Ziyi Jin, Chetasi Talati, Shaji Kumar, Ravi Vij
Publikováno v:
HemaSphere, Vol 7, p e0036307 (2023)
Externí odkaz:
https://doaj.org/article/999772be37cf4e6386e45adb4bad2a1e
Autor:
Ajay K. Nooka, Jonathan L. Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A. Holstein, Larry D. Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, J. Blake Bartlett, Jessica Vermeulen, Thomas S. Lin, Paul G. Richardson, Peter Voorhees
Publikováno v:
Blood Cancer Journal, Vol 12, Iss 4, Pp 1-5 (2022)
Externí odkaz:
https://doaj.org/article/b428bc1646cf491fb069adf05f112f10
Autor:
Jacob P. Laubach, Edward A. Faber, Peter Voorhees, Javid Moslehi, Cindy Varga, Liviu Niculescu, Kenneth C. Anderson, Paul G. Richardson
Publikováno v:
Haematologica, Vol 99, Iss 8 (2014)
Externí odkaz:
https://doaj.org/article/ef380ef367114a7e83a468a2260bbcff
Autor:
Doris K. Hansen, Surbhi Sidana, Lauren C. Peres, Christelle Colin Leitzinger, Leyla Shune, Alexandria Shrewsbury, Rebecca Gonzalez, Douglas W. Sborov, Charlotte Wagner, Danai Dima, Hamza Hashmi, Mehmet H. Kocoglu, Shebli Atrash, Gary Simmons, Nilesh Kalariya, Christopher Ferreri, Aimaz Afrough, Ankit Kansagra, Peter Voorhees, Rachid Baz, Jack Khouri, Melissa Alsina, Joseph McGuirk, Frederick L. Locke, Krina K. Patel
Publikováno v:
Journal of Clinical Oncology. 41:2087-2097
PURPOSE Idecabtagene vicleucel (ide-cel) is an autologous B-cell maturation antigen–directed chimeric antigen receptor T-cell therapy approved for relapsed/refractory multiple myeloma (RRMM) on the basis of the phase II pivotal KarMMa trial, which
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09366877649aa67af7897535ea0e345d
https://doi.org/10.1200/jco.22.01365
https://doi.org/10.1200/jco.22.01365
Autor:
Ajay K Nooka, Jonathan L Kaufman, Cesar Rodriguez, Andrzej Jakubowiak, Yvonne Efebera, Brandi Reeves, Tanya Wildes, Sarah A Holstein, Larry D Anderson, Ashraf Badros, Leyla Shune, Ajai Chari, Huiling Pei, Annelore Cortoos, Sharmila Patel, Thomas S Lin, Paul G Richardson, Peter Voorhees
Publikováno v:
Future Oncology. 18:4443-4456
What is this summary about? This is a summary of a publication about Black participants of the GRIFFIN clinical study that was published in Blood Cancer Journal in April 2022. The GRIFFIN clinical study looked at the treatment combination of daratumu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47dbc0c121be4ca8e423206d901fca66
https://doi.org/10.2217/fon-2022-0775
https://doi.org/10.2217/fon-2022-0775